BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7522396)

  • 21. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea.
    Ballas SK; Marcolina MJ; Dover GJ; Barton FB
    Br J Haematol; 1999 May; 105(2):491-6. PubMed ID: 10233426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemoglobinization and functional availability of iron for erythropoiesis in case of thalassemia and iron deficiency anemia.
    Bartels PC; Schoorl M; Schoorl M
    Clin Lab; 2006; 52(3-4):107-14. PubMed ID: 16584056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of iron deficiency in elite athletes: could microcytic anemia factor (Maf) be useful?
    Dopsaj V; Martinovic J; Dopsaj M
    Int J Lab Hematol; 2014 Feb; 36(1):37-44. PubMed ID: 23731862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron deficiency and sickle cell anemia.
    Rao KR; Patel AR; Honig GR; Vida LN; McGinnis PR
    Arch Intern Med; 1983 May; 143(5):1030-2. PubMed ID: 6679216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.
    Mikobi TM; Lukusa Tshilobo P; Aloni MN; Mvumbi Lelo G; Akilimali PZ; Muyembe-Tamfum JJ; Race V; Matthijs G; Mbuyi Mwamba JM
    PLoS One; 2015; 10(5):e0123568. PubMed ID: 25946088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron restriction in sickle cell disease: When less is more.
    Castro OL; De Franceschi L; Ganz T; Kanter J; Kato GJ; Pasricha SR; Rivella S; Wood JC
    Am J Hematol; 2024 Jul; 99(7):1349-1359. PubMed ID: 38400590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
    Seakins M; Gibbs WN; Milner PF; Bertles JF
    J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of blood transfusion on iron status in sickle cell anaemia.
    Davies S; Henthorn JS; Win AA; Brozovic M
    Clin Lab Haematol; 1984; 6(1):17-22. PubMed ID: 6734096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum transferrin receptor, ferritin, and reticulocyte maturity indices during the first year of life in 'large' preterm infants.
    Schiza V; Giapros V; Pantou K; Theocharis P; Challa A; Andronikou S
    Eur J Haematol; 2007 Nov; 79(5):439-46. PubMed ID: 17916083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy.
    Bhandari S; Norfolk D; Brownjohn A; Turney J
    Am J Kidney Dis; 1997 Dec; 30(6):814-21. PubMed ID: 9398126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term intake of a high zinc diet causes iron deficiency anemia accompanied by reticulocytosis and extra-medullary erythropoiesis.
    Yanagisawa H; Miyakoshi Y; Kobayashi K; Sakae K; Kawasaki I; Suzuki Y; Tamura J
    Toxicol Lett; 2009 Dec; 191(1):15-9. PubMed ID: 19651194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
    Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
    Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of iron restriction in anaemic and non-anaemic patients: New diagnostic approaches.
    Thomas L; Thomas C
    Eur J Haematol; 2017 Sep; 99(3):262-268. PubMed ID: 28618058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Hb F and alpha-thalassemia on the red cell indices in sickle cell anemia.
    Milner PF; Garbutt GJ; Nolan-Davis LV; Jonah F; Wilson LB; Wilson JT
    Am J Hematol; 1986 Apr; 21(4):383-95. PubMed ID: 2420172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major.
    Brittenham GM; Cohen AR; McLaren CE; Martin MB; Griffith PM; Nienhuis AW; Young NS; Allen CJ; Farrell DE; Harris JW
    Am J Hematol; 1993 Jan; 42(1):81-5. PubMed ID: 8416302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron deficiency anaemia in Jamaican children, aged 1-5 years, with sickle cell disease.
    King L; Reid M; Forrester TE
    West Indian Med J; 2005 Oct; 54(5):292-6. PubMed ID: 16459510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.